SHMT2 and cancer: Increased SHMT2 decreases cytosolic levels of serine and phosphoribosylaminoimidazolesuccinocarboxamid (SAICAR), two activators for pyruvate kinase 2 (PKM2), which allows redistribution of glycolytic carbons in support of cancer cell proliferation [3].